MedTrace Logo

Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss

NCT00802425 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2014-06-26

No results posted yet for this study

Summary

The purpose of the study is to determine whether AM-111 is effective in the treatment of acute inner ear hearing loss (acute sensorineural hearing loss, ASNHL).

Conditions

Interventions

DRUG

AM-111

single intratympanic injection

DRUG

placebo

single intratympanic injection

Sponsors & Collaborators

  • Auris Medical AG

    lead INDUSTRY

Principal Investigators

  • Markus M Suckfüll, MD · LMU Munich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2012-07-31
Completion
2012-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00802425 on ClinicalTrials.gov